查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1695304

2025年全基因组和EXOME定序全球市场报告

Whole Genome And Exome Sequencing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年全基因组和EXOME定序市场规模将呈指数级增长。到 2029 年，这一数字将成长至 61.4 亿美元，复合年增长率为 24.9%。预测期内的增长可归因于人口基因组学的努力、精准医疗需求的不断增长、单细胞测序的进步、非侵入性产前检测 (NIPT) 的扩展以及罕见疾病研究中的应用。预测期内的关键趋势包括临床应用的不断增长、定序技术的快速进步、人口规模基因组研究的兴起、人工智慧 (AI) 和机器学习 (ML) 的整合以及在肿瘤学中的应用不断扩大。

个人化医疗日益受到关注，预计将在未来几年推动全基因组和EXOME定序市场的扩张。精准医疗采用量身定制的医疗保健方法，在治疗决策中考虑患者的个人特征，例如遗传、环境和生活方式。全基因组和EXOME定序在个人化医疗中发挥关键作用，它提供对个人基因组成的全面分析，并能够针对特定的遗传、环境和生活方式因素量身定制医疗干预措施。例如，截至2022年10月，个人化医疗联盟（PMC）预测市场上将有超过75,000种基因检测产品和超过300种个人化药物。此外，美国食品药物管理局管理局 (FDA) 药品评估和研究中心 (CDER) 已于 2022 年核准了37 个新分子实体 (NME)，其中约 34% 的 35 个治疗性 NME 被归类为个人化药物。因此，对个人化医疗的需求不断增长，刺激了全基因组和EXOME定序市场的扩张。

为了获得竞争优势，全基因组和EXOME定序市场的主要企业正在加强开发最尖端科技解决方案，尤其是超快速 NGS（次世代定序仪）分析。这项创新有助于快速处理NGS资料，大幅缩短分析时间。例如，美国生物资讯公司QIAGEN Digital Insights（QDI）于2023年1月宣布推出超快速NGS分析平台，该平台拥有仅需25分钟即可处理整个基因组、云端运算成本仅为1美元等特点，提升了效率、可负担性和扩充性。这项技术突破显着提高了基因组资料分析的速度和可近性，实现了更快的决策和个人化医疗的广泛应用，在整个基因组和EXOME定序市场中发挥关键作用。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球全基因组与EXOME定序PESTEL分析（政治、社会、科技、环境、法律、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球全基因组与EXOME定序市场：成长率分析
  • 全球全基因组与EXOME定序市场表现：规模与成长，2019-2024
  • 全球全基因组与EXOME定序市场预测：规模与成长，2024-2029 年，2034 年
  • 全球全基因组和EXOME定序总目标市场（TAM）

第六章市场区隔

  • 全球全基因组和EXOME定序市场（按产品类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 套件
  • 装置
  • 全球全基因组和EXOME定序市场（按工作流程、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 全基因组定序（WGS）
  • 全外EXOME定序（WES）
  • 全球全基因组和EXOME定序市场（按应用、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 诊断
  • 癌症
  • 单基因疾病
  • 糖尿病
  • 药物研发
  • 个人化医疗
  • 农业和动物研究
  • 其他用途
  • 全球全基因组和EXOME定序市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 研究中心
  • 学术和政府机构
  • 医院和诊所
  • 製药和生物技术公司
  • 其他最终用户
  • 全球全基因组及EXOME定序市场、套件细分、类型、效能及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 文库製备试剂套件
  • 靶向序列捕获套件
  • DNA萃取试剂套件
  • 全球全基因组和EXOME定序市场，仪器细分，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 次世代定序（NGS）系统
  • 桑格定序系统
  • 第三代定序系统

第七章 区域和国家分析

  • 全球全基因组和EXOME定序市场：区域、历史和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球全基因组及EXOME定序市场：依国家/地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 全基因组与EXOME定序市场：竞争格局
  • 全基因组和EXOME定序市场：公司简介
    • Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Cytiva（Danaher Corporation）Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation of America Holdings（Labcorp）Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Eurofins Scientific SE
  • Agilent Technologies Inc.
  • Illumina Inc.
  • Canon Medical Systems Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Neusoft Corporation
  • BGI Genomics
  • Mirion Technologies（Capintec）Inc.
  • Novogene Co.
  • Oxford Nanopore Technologies Inc.
  • LANDAUER
  • Pacific Biosciences of California Inc.
  • Digirad Corporation
  • Berthold Technologies GmbH & Co. KG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年全基因组和EXOME定序市场：提供新机会的国家
  • 2029 年全基因组与EXOME定序市场：细分领域带来新机会
  • 2029 年全基因组与EXOME定序市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r29284

Whole genome sequencing (WGS) and exome sequencing (ES) are advanced genetic analysis methodologies aimed at deciphering an organism's complete DNA sequence and specifically targeting the protein-coding regions of the genome. These techniques play a crucial role in diagnosing genetic disorders and identifying cancer-related mutations.

The primary product categories in WGS and ES comprise kits and instruments, where kits encompass a collection of related products packaged together for simplified inventory management. Various workflows such as whole genome sequencing (WGS) and whole exome sequencing (WES) are utilized across multiple applications including diagnostics, cancer research, monogenic disorders, drug development, personalized medicine, agriculture, and animal research. End users encompass diverse entities such as research centers, academic institutions, governmental bodies, hospitals, pharmaceutical and biotechnology companies, among others.

The whole genome and exome sequencing market research report is one of a series of new reports from The Business Research Company that provides whole genome and exome sequencing market statistics, including whole genome and exome sequencing industry global market size, regional shares, competitors with a whole genome and exome sequencing market share, detailed whole genome and exome sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the whole genome and exome sequencing industry. This whole genome and exome sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The whole genome and exome sequencing market size has grown exponentially in recent years. It will grow from $2.02 billion in 2024 to $2.53 billion in 2025 at a compound annual growth rate (CAGR) of 24.8%. The growth in the historic period can be attributed to decreasing sequencing costs, rise in genetic disorders, clinical applications, genomic data repositories, advancements in bioinformatics.

The whole genome and exome sequencing market size is expected to see exponential growth in the next few years. It will grow to $6.14 billion in 2029 at a compound annual growth rate (CAGR) of 24.9%. The growth in the forecast period can be attributed to population genomics initiatives, rising demand for precision medicine, advancements in single-cell sequencing, expansion of non-invasive prenatal testing (NIPT), application in rare disease research. Major trends in the forecast period include expanded clinical adoption, rapid advancements in sequencing technologies, rise of population-scale genomic studies, integration of artificial intelligence (AI) and machine learning (ML), expanding applications in oncology.

The increasing interest in personalized medicine is anticipated to drive the expansion of the whole genome and exome sequencing market in the coming years. Personalized medicine adopts a tailored approach to healthcare, considering individual patient characteristics such as genetics, environment, and lifestyle in treatment decisions. Whole genome and exome sequencing play a pivotal role in personalized medicine by offering a comprehensive analysis of an individual's genetic composition, enabling healthcare interventions customized to their specific genetic, environmental, and lifestyle factors. For example, as of October 2022, the Personalized Medicine Coalition (PMC) projects over 75,000 genetic testing products and 300 personalized medicines to be available on the market. Additionally, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022, with approximately 34% classified as personalized among the 35 therapeutic NMEs. Consequently, the growing demand for personalized medicine is fueling the expansion of the whole genome and exome sequencing market.

Major players in the whole genome and exome sequencing markets are intensifying their efforts towards developing cutting-edge technological solutions, notably ultra-fast NGS (next-generation sequencing) analysis, to gain a competitive advantage. This innovation facilitates the rapid processing of NGS data, drastically reducing analysis time. For example, in January 2023, QIAGEN Digital Insights (QDI), a US-based bioinformatics company, introduced an ultra-fast NGS analysis platform. This platform boasts features such as processing a whole genome in just 25 minutes at a cost of $1 in cloud computing expenses, promoting efficiency, affordability, and scalability. Its technological breakthrough significantly enhances the speed and accessibility of genomic data analysis, playing a crucial role in the whole genome and exome sequencing market by enabling swift decision-making and wider adoption of personalized medicine.

In January 2023, QIAGEN, a multinational corporation headquartered in Germany and specializing in sample technologies and molecular insights products, acquired Verogen for an undisclosed sum. This acquisition bolsters QIAGEN's presence in the human identification and forensics market, consolidating its leadership position and facilitating the creation of more comprehensive solutions with potential implications for the entire genome and exome sequencing market. Verogen, based in the United States, is a biotech company that offers next-generation sequencing (NGS) tools and services, including whole genome and exome sequencing.

Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan

North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the whole genome and exome sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The whole genome and exome sequencing market consists of revenues earned by entities by providing services such as genetic profiling, variant identification, personalized medicine solutions, and comprehensive genomic analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The whole genome and exome sequencing market also includes sales of exome capture kits, benchtop sequencer, and sample preparation instrutments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Whole Genome And Exome Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on whole genome and exome sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for whole genome and exome sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The whole genome and exome sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Kits; Instruments
  • 2) By Workflow: Whole Genome Sequencing (WGS); Whole Exome Sequencing (WES)
  • 3) By Applications: Diagnostics; Cancer; Monogenic Disorders; Diabetes; Drug Discovery And Development; Personalized Medicine; Agriculture And Animal Research; Other Applications
  • 4) By End user: Research Center; Academic And Government Institutions; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
  • Subsegments:
  • 1) By Kits: Library Preparation Kits; Target Enrichment Kits; DNA Extraction Kits
  • 2) By Instruments: Next-Generation Sequencing (NGS) Systems; Sanger Sequencing Systems; Third-Generation Sequencing Systems
  • Companies Mentioned: Siemens AG; Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Cytiva (Danaher Corporation); Laboratory Corporation of America Holdings (Labcorp)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Whole Genome And Exome Sequencing Market Characteristics

3. Whole Genome And Exome Sequencing Market Trends And Strategies

4. Whole Genome And Exome Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Whole Genome And Exome Sequencing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Whole Genome And Exome Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Whole Genome And Exome Sequencing Market Growth Rate Analysis
  • 5.4. Global Whole Genome And Exome Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Whole Genome And Exome Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Whole Genome And Exome Sequencing Total Addressable Market (TAM)

6. Whole Genome And Exome Sequencing Market Segmentation

  • 6.1. Global Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kits
  • Instruments
  • 6.2. Global Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • 6.3. Global Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics
  • Cancer
  • Monogenic Disorders
  • Diabetes
  • Drug Discovery And Development
  • Personalized Medicine
  • Agriculture And Animal Research
  • Other Applications
  • 6.4. Global Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Center
  • Academic And Government Institutions
  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Companies
  • Other End Users
  • 6.5. Global Whole Genome And Exome Sequencing Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Library Preparation Kits
  • Target Enrichment Kits
  • DNA Extraction Kits
  • 6.6. Global Whole Genome And Exome Sequencing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS) Systems
  • Sanger Sequencing Systems
  • Third-Generation Sequencing Systems

7. Whole Genome And Exome Sequencing Market Regional And Country Analysis

  • 7.1. Global Whole Genome And Exome Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Whole Genome And Exome Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Whole Genome And Exome Sequencing Market

  • 8.1. Asia-Pacific Whole Genome And Exome Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Whole Genome And Exome Sequencing Market

  • 9.1. China Whole Genome And Exome Sequencing Market Overview
  • 9.2. China Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Whole Genome And Exome Sequencing Market

  • 10.1. India Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Whole Genome And Exome Sequencing Market

  • 11.1. Japan Whole Genome And Exome Sequencing Market Overview
  • 11.2. Japan Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Whole Genome And Exome Sequencing Market

  • 12.1. Australia Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Whole Genome And Exome Sequencing Market

  • 13.1. Indonesia Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Whole Genome And Exome Sequencing Market

  • 14.1. South Korea Whole Genome And Exome Sequencing Market Overview
  • 14.2. South Korea Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Whole Genome And Exome Sequencing Market

  • 15.1. Western Europe Whole Genome And Exome Sequencing Market Overview
  • 15.2. Western Europe Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Whole Genome And Exome Sequencing Market

  • 16.1. UK Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Whole Genome And Exome Sequencing Market

  • 17.1. Germany Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Whole Genome And Exome Sequencing Market

  • 18.1. France Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Whole Genome And Exome Sequencing Market

  • 19.1. Italy Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Whole Genome And Exome Sequencing Market

  • 20.1. Spain Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Whole Genome And Exome Sequencing Market

  • 21.1. Eastern Europe Whole Genome And Exome Sequencing Market Overview
  • 21.2. Eastern Europe Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Whole Genome And Exome Sequencing Market

  • 22.1. Russia Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Whole Genome And Exome Sequencing Market

  • 23.1. North America Whole Genome And Exome Sequencing Market Overview
  • 23.2. North America Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Whole Genome And Exome Sequencing Market

  • 24.1. USA Whole Genome And Exome Sequencing Market Overview
  • 24.2. USA Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Whole Genome And Exome Sequencing Market

  • 25.1. Canada Whole Genome And Exome Sequencing Market Overview
  • 25.2. Canada Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Whole Genome And Exome Sequencing Market

  • 26.1. South America Whole Genome And Exome Sequencing Market Overview
  • 26.2. South America Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Whole Genome And Exome Sequencing Market

  • 27.1. Brazil Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Whole Genome And Exome Sequencing Market

  • 28.1. Middle East Whole Genome And Exome Sequencing Market Overview
  • 28.2. Middle East Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Whole Genome And Exome Sequencing Market

  • 29.1. Africa Whole Genome And Exome Sequencing Market Overview
  • 29.2. Africa Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Whole Genome And Exome Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Whole Genome And Exome Sequencing Market Competitive Landscape
  • 30.2. Whole Genome And Exome Sequencing Market Company Profiles
    • 30.2.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Cytiva (Danaher Corporation) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Laboratory Corporation of America Holdings (Labcorp) Overview, Products and Services, Strategy and Financial Analysis

31. Whole Genome And Exome Sequencing Market Other Major And Innovative Companies

  • 31.1. Eurofins Scientific SE
  • 31.2. Agilent Technologies Inc.
  • 31.3. Illumina Inc.
  • 31.4. Canon Medical Systems Corporation
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. QIAGEN N.V.
  • 31.7. Neusoft Corporation
  • 31.8. BGI Genomics
  • 31.9. Mirion Technologies (Capintec) Inc.
  • 31.10. Novogene Co.
  • 31.11. Oxford Nanopore Technologies Inc.
  • 31.12. LANDAUER
  • 31.13. Pacific Biosciences of California Inc.
  • 31.14. Digirad Corporation
  • 31.15. Berthold Technologies GmbH & Co. KG

32. Global Whole Genome And Exome Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Whole Genome And Exome Sequencing Market

34. Recent Developments In The Whole Genome And Exome Sequencing Market

35. Whole Genome And Exome Sequencing Market High Potential Countries, Segments and Strategies

  • 35.1 Whole Genome And Exome Sequencing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Whole Genome And Exome Sequencing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Whole Genome And Exome Sequencing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer